| 臺大學術典藏 |
2020-12-02T02:34:20Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:18Z |
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer
|
Wu J.-Y.;Yu C.-J.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:17Z |
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer
|
Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:10Z |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:10Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:09Z |
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
|
Wu J.-Y.;Yu C.-J.;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; Wu C.-T.; Chang Y.-L.; Jou Y.-S.; Hong T.-M.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:59Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:52Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:44Z |
Overcoming EGFR T790M-based tyrosine kinase inhibitor resistance with an allele-specific DNAzyme
|
Lai W.-Y.;Chen C.-Y.;Yang S.-C.;Wu J.-Y.;Chang C.-J.;PAN-CHYR YANG;Peck K.; Lai W.-Y.; Chen C.-Y.; Yang S.-C.; Wu J.-Y.; Chang C.-J.; PAN-CHYR YANG; Peck K. |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chien-Chuan Chen; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chien-Chuan Chen; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Tsao F.-Y.; Liu T.-Y.; Hsieh C.-F.; Bair M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Chien-Chuan Chen; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C. |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chun-Chao Chang; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Wu M.-S.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:33Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chien-Chuan Chen; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:31Z |
Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus
|
Liou J.-M.; Malfertheiner P.; Lee Y.-C.; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; Chen M.-J.; Chiang T.-H.; CHIEH-CHANG CHEN; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; Hong T.-C.; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; Wu M.-S.; El-Omar E.M. |
| 臺大學術典藏 |
2020-11-23T07:25:37Z |
Adrenal insufficiency in prolonged critical illness
|
Wu J.-Y.;Hsu S.-C.;Shih-Chi Ku;Ho C.-C.;Yu C.-J.;Yang P.-C.; Wu J.-Y.; Hsu S.-C.; SHIH-CHI KU; Ho C.-C.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-11-23T07:25:36Z |
The role of chest radiography in the suspicion for and diagnosis of pulmonary tuberculosis in intensive care units
|
Yu C-J.; Chen Y-C.; Wu J-Y.; SHIH-CHI KU; Shu C-C.; Fan J-Y.; Chen H-Y. |
| 臺大學術典藏 |
2020-11-18T05:27:57Z |
Runs of Homozygosity Associated with Speech Delay in Autism in a Taiwanese Han Population: Evidence for the Recessive Model
|
Lin P.-I.;Po-Hsiu Kuo;Chen C.-H.;Wu J.-Y.;Gau S.S.-F.;Wu Y.-Y.;Liu S.-K.; Lin P.-I.; PO-HSIU KUO; Chen C.-H.; Wu J.-Y.; Gau S.S.-F.; Wu Y.-Y.; Liu S.-K. |
| 臺大學術典藏 |
2020-11-18T05:27:54Z |
Investigation of associations between NR1D1, RORA and RORB genes and bipolar disorder
|
Lai Y.-C.;Kao C.-F.;Lu M.-L.;Chen H.-C.;Chen P.-Y.;Chen C.-H.;Shen W.W.;Wu J.-Y.;Lu R.-B.;Po-Hsiu Kuo; Lai Y.-C.; Kao C.-F.; Lu M.-L.; Chen H.-C.; Chen P.-Y.; Chen C.-H.; Shen W.W.; Wu J.-Y.; Lu R.-B.; PO-HSIU KUO |
| 臺大學術典藏 |
2020-11-18T05:27:52Z |
Identification of susceptible loci and enriched pathways for Bipolar II disorder using genome-wide association studies
|
Kao C.-F.;Chen H.-W.;Chen H.-C.;Yang J.-H.;Huang M.-C.;Chiu Y.-H.;Lin S.-K.;Lee Y.-C.;Liu C.-M.;Chuang L.-C.;Chen C.-H.;Wu J.-Y.;Lu R.-B.;Po-Hsiu Kuo; Kao C.-F.; Chen H.-W.; Chen H.-C.; Yang J.-H.; Huang M.-C.; Chiu Y.-H.; Lin S.-K.; Lee Y.-C.; Liu C.-M.; Chuang L.-C.; Chen C.-H.; Wu J.-Y.; Lu R.-B.; PO-HSIU KUO |
